What is Stent for Life Initiative
   
Mission
   
Objectives
   
   
Participating organizations
   
Project Executive Board
   
Project Partners
   
Scientific Evidence
   
News and Press Release
   
Contact
   
 
Stent for Life – Scientific Evidence
  
     
     
 
1. Stent for Life articles in major publications
  
     
   
 
Widimsky P, Fajadet J, Danchin N, Wijns W
  
 
EuroInterv.2009;4:555-557.
  
   
   
 
Knot J, Widimsky P, Wijns W, Stenestrand U, Kristensen S, van't Hof A, Weidinger F, Janzon M, Nörgaard B, Soerensen J, van de Wetering H, Thygesen K, Bergsten P, Digerfeldt C, Potgieter A, Tomer N, Fajadet J
  
 
EuroIntervention 2009;5:299-309.
  
     
   
 
Petr Widimsky*, William Wijns, Jean Fajadet, Mark de Belder, Jiri Knot, Lars Aaberge, George Andrikopoulos, Jose Antonio Baz, Amadeo Betriu, Marc Claeys, Nicholas Danchin, Slaveyko Djambazov, Paul Erne, Juha Hartikainen, Kurt Huber, Petr Kala, Milka Klinceva, Steen Dalby Kristensen, Peter Ludman, Josephina Mauri Ferre, Bela Merkely, Davor Milicic, Joao Morais, Marko Noc, Grzegorz Opolski, Miodrag Ostojic, Dragana Radovanovic, Stefano De Servi, Ulf Stenestrand, Martin Studencan, Marco Tubaro, Zorana Vasiljevic, Franz Weidinger, Adam Witkowski, and Uwe Zeymer on behalf of the European Association for Percutaneous Cardiovascular Interventions
  
  Eur Heart J. 2010 Apr;31(8):943-57. Epub 2009 Nov 19.  
     
 
2. Guidelines
  
     
 
STEMI
  
 
Van de Werf F, Bax J, Betriu A, Blomstrom–Lundqvist C, Crea F, Falk V, Filippatos G, Fox K, Huber K, Kastrati A, Rosengren A, Steg PG, Tubaro M, Verheugt F, Weidinger F, Weis M; ESC Committee for Practice Guidelines (CPG), Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck–Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Silber S, Aguirre FV, Al–Attar N, Alegria E, Andreotti F, Benzer W, Breithardt O, Danchin N, Di Mario C, Dudek D, Gulba D, Halvorsen S, Kaufmann P, Kornowski R, Lip GY, Rutten F. Management of acute myocardial infarction in patients presenting with persistent ST–segment elevation: the Task Force on the Management of ST–Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology.
 
 
Eur Heart J. 2008 Dec;29(23):2909–45.
  
     
 
Non–STE ACS
  
 
Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernandez–Aviles F, Fox KA, Hasdai D, Ohman EM, Wallentin L, Wijns W; ESC Committee for Practice Guidelines (CPG), Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Kristensen SD, Widimsky P, McGregor K, Sechtem U, Tendera M, Hellemans I, Gomez JL, Silber S, Funck–Brentano C; Document Reviewers, Kristensen SD, Andreotti F, Benzer W, Bertrand M, Betriu A, De Caterina R, Desutter J, Falk V, Ortiz AF, Gitt A, Hasin Y, Huber K, Kornowski R, Lopez–Sendon J, Morais J, Nordrehaug JE, Silber S, Steg PG, Thygesen K, Tubaro M, Turpie AG, Verheugt F, Windecker S. Guidelines for the diagnosis and treatment of non–ST–segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non–ST–Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology.
 
 
Eur Heart J 2007; 28: 1598–660.
  
   
 
PCI
  
 
Silber S, Albertsson P, Aviles FF, Camici PG, Colombo A, Hamm C, Jorgensen E, Marco J, Nordrehaug JE, Ruzyllo W, Urban P, Stone GW, Wijns W. Guidelines for percutaneous coronary interventions – The task force for percutaneous coronary interventions of the European Society of Cardiology.
 
Eur Heart J 2005; 26: 804–47.
  
     
 
AMI Definition
  
 
Thygesen K, Alpert JS, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Jaffe AS, Apple FS, Galvani M, Katus HA, Newby LK, Ravkilde J, Chaitman B, Clemmensen PM, Dellborg M, Hod H, Porela P, Underwood R, Bax JJ, Beller GA, Bonow R, Van der Wall EE, Bassand JP, Wijns W, Ferguson TB, Steg PG, Uretsky BF, Williams DO, Armstrong PW, Antman EM, Fox KA, Hamm CW, Ohman EM, Simoons ML, Poole–Wilson PA, Gurfinkel EP, Lopez–Sendon JL, Pais P, Mendis S, Zhu JR, Wallentin LC, Fernández–Avilés F, Fox KM, Parkhomenko AN, Priori SG, Tendera M, Voipio–Pulkki LM, Vahanian A, Camm AJ, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck–Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Morais J, Brener S, Harrington R, Morrow D, Lim M, Martinez–Rios MA, Steinhubl S, Levine GN, Gibler WB, Goff D, Tubaro M, Dudek D, Al–Attar N. Universal definition of myocardial infarction.
 
 
Circulation. 2007 Nov 27;116(22):2634–53.
  
     
 
3. Randomized trials
  
     
 
Zwolle Trial nr. 1
  
 
Zijlstra F, de Boer MJ, Hoorntje JC, Reiffers S, Reiber JH, Suryapranata H A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction.
 
 
N Engl J Med. 1993; 328: 680–4.
  
     
 
LIMI Study
  
 
Vermeer F, Oude Ophuis AJ, vd Berg EJ, Brunninkhuis LG, Werter CJ, Boehmer AG, Lousberg AH, Dassen WR, Bär FW.Prospective randomised comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: a safety and feasibility study.
  
 
Heart 1999; 82: 426–31.
 
     
 
PRAGUE Study.
  
 
Widimsky P, Groch L, Zelizko M, Aschermann M, Bednar F, Suryapranata H. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study.
  
 
Eur Heart J. 2000 May;21(10):823–31.
  
     
 
DANAMI–2 trial
  
 
Andersen HR, Nielsen TT, Rasmussen K, Thuesen L, Kelbaek H, Thayssen P, Abilgaard U, Pedersen F, Madsen JK, Grande P, Villadsen AB, Krusell LR, Haghfelt T, Lomholt P, Husted SE, Vigholt E, Kjaergard HK, Mortensen LS. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction.
 
 
Eur Heart J. 2000 May;21(10):823–31.
  
     
 
ASSENT–4 Trial.
  
 
The Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT– 4 PCI) investigators. Primary versus tenecteplase facilitated percutaneous coronary intervention in patients with ST– elevation acute myocardial Infarction: the ASSENT– 4 PCI randomised trial.
 
 
Lancet 2006; 367: 569–78.
  
     
 
FINESSE trial.
  
 
Ellis SG, Tendera M, de Belder MA, van Boven AJ, Widimsky P, Janssens L, Andersen HR, Betriu A, Savonitto S, Adamus J, Peruga JZ, Kosmider M, Katz O, Neunteufl T, Jorgova J, Dorobantu M, Grinfeld L, Armstrong P, Brodie BR, Herrmann HC, Montalescot G, Neumann FJ, Effron MB, Barnathan ES, Topol EJ; FINESSE Investigators. Facilitated PCI in patients with ST–elevation myocardial infarction.
 
 
N Engl J Med. 2008 May 22;358(21):2205–17.
  
     
 
VINO Study.
  
 
Spacek R, Widimsky P, Straka Z, Jiresova E, Dvorak J, Polasek R, Karel I, Jirmar R, Lisa L, Budesinsky T, Malek F, Stanka P. Value of first day angiography/angioplasty in evolving Non–ST segment elevation myocardial infarction: an open multicenter randomized trial. The VINO Study.
 
 
Eur Heart J. 2002 Feb;23(3):230–8.
  
     
 
PRAGUE–2 Trial.
  
 
Widimsky P, Budesinsky T, Vorac D, Groch L, Zelizko M, Aschermann M, Branny M, St’asek J, Formanek P; "PRAGUE" Study Group Investigators. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial––PRAGUE–2.
  
 
Eur Heart J. 2003 Jan;24(1):94–104.
  
     
 
Petr Widimsky, Dana Bilkova, Martin Penicka, Martin Novak, Miroslava Lanikova, Vladimir Porizka, Ladislav Groch, Michael Zelizko, Tomas Budesinsky, and Michael Aschermann on behalf of the PRAGUE Study Group Investigators. Long–term outcomes of patients with acute myocardial infarction presenting to hospitals without catheterization laboratory and randomized to immediate thrombolysis or interhospital transport for primary percutaneous coronary intervention. Five years’ follow–up of the PRAGUE–2 trial.
 
 
Eur Heart J 28; 2007: 679–84.
  
     
 
4. Metaanalyses
  
     
 
Keeley EC, Boura JA, Grines C. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction : a quantitative review of 23 randomized trials.
 
 
Lancet 2003; 361: 13–20.
  
     
 
Mehta SR, Cannon CP, Fox KAA, Wallentin L, Boden WE, Spacek R, Widimsky P, McCullough PA, Hunt D, Braunwald E, Yusuf S. Routine versus Selective Invasive Strategies in Patients with Acute Coronary Syndromes: A collaborative meta–analysis of the randomized trials.
 
 
JAMA 2005; 293: 2908–2917.
  
     
 
PCAT Collaborative Group (Boersma E, et al.) Does time matter ? An individual patient data–based meta–analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in–hospital fibrinolysis.
 
 
Eur Heart J 2006; 27: 779–788.
  
     
 
5. Registries
  
     
 
Petr Widimsky, Michal Zelizko, Petr Jansky, Frantisek Tousek, Frantisek Holm and Michael Aschermann on behalf of the CZECH investigators. The incidence, treatment strategies and outcomes of acute coronary syndromes in the "reperfusion network" of different hospital types in the Czech Republic: Results of the CZech Evaluation of acute Coronary syndromes in Hospitalized patients (CZECH) Registry.
 
 
Intern J Cardiol 119 (2007) 212–219.
  
     
 
Tadel Kocjancic S, Zorman S, Jazbec A, Gorjup V, Zorman D, Noc M. Effectiveness of primary percutaneous coronary intervention for acute ST–elevation myocardial infarction from a 5–year single–center experience.
 
 
Am J Cardiol 2008; 101: 162–8.
  
     
 
Di Chiara A, Fresco C, Savonitto S, Greco C, Lucci D, Gonzini L, Mafrici A, Ottani F, Bolognese L, De Servi S, Boccanelli A, Maggioni AP, Chiarella F; BLITZ–2 Investigators. Epidemiology of non–ST elevation acute coronary syndromes in the Italian cardiology network: the BLITZ–2 study.
 
 
Eur Heart J 2006; 27: 393–405.
  
     
 
Andrikopoulos G, Pipilis A, Goudevenos J, Tzeis S, Kartalis A, Oikonomou K, Karvounis H, Mantas J, Kyrpizidis C, Gotsis A, Paschidi M, Tsaknakis T, Pyrgakis V, Manolis AS, Boudoulas H, Vardas P, Stefanadis C, Lekakis J. On behalf of the HELIOS study investigators. Epidemiological characteristics, management and early outcome of acute myocardial infarction in Greece. The HELlenic Infarction Observation Study.
 
 
Hellenic J Cardiol 2007 Nov–Dec;48(6):325–34.
  
     
 
Pipilis A, Andrikopoulos G, Lekakis J, Kalantzi K, Kitsiou A, Toli K, Floros D, Karalis J, Dragomanovits S, Kalogeropoulos P, Synetos A, Koutsogiannis N, Stougiannos P, Antonakoudis H, Goudevenos J, on behalf of the HELIOS group. Outcome of patients with acute myocardial infarction admitted in hospitals with or without catheterization laboratory: results from the HELIOS registry.
 
 
Eur J Cardiovasc Prevention Rehab 2009;16: 85–90.
  
     
 
Marrugat, J; Elosua, R; Marti, H Epidemiology of ischaemic heart disease in Spain: Estimation of the number of cases and trends from 1997 to 2005.
 
 
Rev Esp Cardiol 2002;55:337–46.
  
     
 
Salomaa V, Ketonen M, Koukkunen H, Immonen–Räihä P, Jerkkola T, Kärjä–Koskenkari P, Mähönen M, Niemelä M, Kuulasmaa K, Palomäki P, Mustonen J, Arstila M, Vuorenmaa T, Lehtonen A, Lehto S, Miettinen H, Torppa J, Tuomilehto J, Kesäniemi YA, Pyörälä K. Decline in out–of–hospital coronary heart disease deaths has contributed the main part to the overall decline in coronary heart disease mortality rates among persons 35 to 64 years of age in Finland: the FINAMI study.
 
 
Circulation 2003; 108: 691–6.
  
     
 
Pajunen P, Koukkunen H, Ketonen M, Jerkkola T, Immonen–Räihä P, Kärjä–Koskenkari P, Mähonen M, Niemelä M, Kuulasmaa K, Palomäki P, Mustonen J, Lehtonen A, Arstila M, Vuorenmaa T, Lehto S, Miettinen H, Torppa J, Tuomilehto J, Kesäniemi YA, Pyoräulä K, Salomaa V.: The validity of the Finnish Hospital Discharge Register and Causes of Death Register data on coronary heart disease.
 
 
Eur J Cardiovasc Prev Rehabil. 2005; 12: 132–7.
  
     
 
Goldberg RJ, Spencer FA, Fox KAA, Brieger D, Steg PG, Gurfinkel E, Dedrick R, Gore JM. Prehospital Delay in Patients With Acute Coronary Syndromes (from the Global Registry of Acute Coronary Events [GRACE]).
  
 
Am J Cardiol 2009; 103: 598–603.
  
     
 
Mandelzweig L, Battler A, Boyko V, Bueno H, Danchin N, Filippatos G, Gitt A, Hasdai D, Hasin Y, Marrugat J, Van de Werf F, Wallentin L, Behar S. The second Euro Heart Survey on acute coronary syndromes: Characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004.
 
 
Eur Heart J 2006; 27: 2285–2293.
  
     
 
Koek HL, van Dis SJ, Peters RJG, Bots ML: Hart– en vaatziekten in Nederland.
 
 
In: Hart en vaatziekten in Nederland 2005, Nederlandse Hartstichting, den Haag, 2005, p. 9–32.
  
     
 
Stenestrand U, Lindbäck J, Wallentin L for the RIKS–HIA group. Long–term outcome of primary percutaneous coronary intervention vs prehospital and in–hospital thrombolysis for patients with ST–elevation myocardial infarction.
 
 
JAMA 2006; 296: 1749–56.
  
     
 
Bjorklund E, Lindahl B, Stenestrand U, Swahn E, Dellborg M, Pehrsson K, Van De Werf F, Wallentin L; Swedish ASSENT–2; RIKS–HIA Investigators. Outcome of ST–elevation myocardial infarction treated with thrombolysis in the unselected population is vastly different from samples of eligible patients in a large–scale clinical trial.
 
 
Am Heart J 2004; 148: 566–73.
  
     
 
Danchin N, Coste P, Ferrières J, Steg PG, Cottin Y, Blanchard D, Belle L, Ritz B, Kirkorian G, Angioi M, Sans P, Charbonnier B, Eltchaninoff H, Guéret P, Khalife K, Asseman P, Puel J, Goldstein P, Cambou JP, Simon T for the FAST–MI Investigators. Comparison of Thrombolysis Followed by Broad Use of Percutaneous Coronary Intervention With Primary Percutaneous Coronary Intervention for ST–Segment–Elevation Acute Myocardial Infarction Data From the French Registry on Acute ST–Elevation Myocardial Infarction (FAST–MI).
 
 
Circulation 2008; 118: 268–276.
  
     
 
Kalla K, Christ G, Karnik R, Malzer R, Norman G, Prachar H, Schreiber W, Unger G, Glogar HD, Kaff A, Laggner AN, Maurer G, Mlczoch J, Slany J, Weber HS, Huber K; Vienna STEMI Registry Group. Implementation of guidelines improves the standard of care: the Viennese registry on reperfusion strategies in ST–elevation myocardial infarction (Vienna STEMI registry).
 
 
Circulation 2006; 113: 2398–2405.
  
     
 
Mandelzweig L, Battler A, Boyko V, Bueno H, Danchin N, Filippatos G, Gitt A, Hasdai D, Hasin Y, Marrugat J, Van de Werf F, Wallentin L, Behar S. The second Euro Heart Survey on acute coronary syndromes: Characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004.
 
 
Eur Heart J 2006; 27: 2285–2293.
  
     
 
Mühlberger V, Pachinger O. Herzkathetereingriffe in Osterreich im Jahr 2007 (mit Audit 2004–2008).
 
 
J Kardiol 2009; 16: 86–103
  
     
 
Suessenbacher A, Doerler J, Alber H, Altenberger J, Christ G, Globits S, Huber K, Karnik R, Norman G, Zenker G, Pachinger O, Weidinger F. Gender–related outcome following precutaneous coronary intervention for ST–elevation myocardial infarction: data from the Asutrian Acute PCI Registry.
 
 
Eurointerv 2008; 4: 271–276.
  
     
   
     
   
     
   
     
 
Brocco S, Fedeli U, Schievano E, Milan G, Avossa F, Visentin C, Alba N, Olivari Z, Di Pede F, Spolaore P. Effect of the new diagnostic criteria for ST–elevation and non–ST–elevation acute myocardial infarction on 4–year hospitalization: an analysis of hospital discharge records in the Veneto Region.
  
 
J Cardiovasc Med (Hagerstown). 2006 Jan;7(1):45–50
  
     
 
Ferreira J, Monteiro P, Mimoso J. National Registry of Acute Coronary Syndromes: results of the hospital phase in 2002.
  
 
Rev Port Cardiol. 2004 Oct;23(10):1251–72.
  
     
   
     
 
Baz JA, Pinar E, Albarrán A, Mauri J; Spanish Society of Cardiology Working Group on Cardiac Catheterization and Interventional Cardiology. Spanish Cardiac Catheterization and Coronary Intervention Registry. 17th official report of the Spanish Society of Cardiology Working Group on Cardiac Catheterization and Interventional Cardiology (1990–2007).
  
 
Rev Esp Cardiol. 2008 Dec;61(12):1298–314
  
     
 
Jeger R, Radovanovic D, Hunziker P, Pfisterer M, Stauffer J–C, Erne P, Urban P. Ten–year trends in the incidence and treatment of cardiogenic shock.
 
 
Ann Intern Med 2008; 149:618–26.
  
     
 
Schoenenberger AW, Radovanovic D, Stauffer J–C, Windecker S, Urban P, Eberli FR, Stuck AE, Gutzwiller F, Erne P, for the Acute Myocardial Infarction in Switzerland Plus Investigators. Age–related differences in the use of guideline–recommended medical and interventional therapies for acute coronary syndromes: a cohort study.
  
 
J Am Geriatr Soc 2008; 56:510–6.
  
     
 
Radovanovic D, Erne P, Urban P, Bertel O, Rickli H, Gaspoz J–M. Gender differences in management and outcomes in patients with acute coronary syndromes. Results on 20 290 patients from the AMIS Plus registry.
 
 
Heart 2007; 93:1369–75.
  
     
 
Maeder M, Stauffer J–C, Windecker S, Pedrazzini G, Kaiser C, Roffi M, Rickli H on behalf of the Working Group "Interventional Cardiology and Acute Coronary Syndrome". Interventional cardiology in Switzerland 2006.
 
 
Kardiovaskuläre Medizin 2008; 11: 187–95.
  
     
 
6. Other references
  
     
 
ESC Policy Statement.
  
 
Bassand JP, Danchin N, Filippatos G, Gitt A, Hamm C, Silber S, Tubaro M, Weidinger F. Implementation of reperfusion therapy in acute myocardial infarction. A policy statement from the European Society of Cardiology.
 
 
Eur Heart J 2005; 26: 2733–41.
  
     
 
Normal CAG in STEMI
  
 
Widimský P, Štellová B, Groch L, Vorác D, Bednár F, Aschermann M, Branny M, Zelízko M, Š’ásek J, Formánek P. Prevalence of normal coronary angiogram in the acute phase of suspected ST elevation myocardial infarction: experience from the PRAGUE studies.
 
 
Canad J Cardiol 22; 2006: 1147–1152.
  
   
 
Five–years outcomes after primary PCI
  
 
G Parodi, G Memisha, R Valenti, M Trapani, A Migliorini, G M Santoro, D Antoniucci. Five year outcome after primary coronary intervention for acute ST elevation myocardial infarction: results from a single centre experience.
 
Heart 2005;91:1541–1544.